- Meridian Bioscience to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on November 12, 2021
- Meridian Launches New Air-Dryable™ qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples
- Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples
- Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples
- Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare Test Kits
- Meridian Bioscience to Present at the H. C. Wainwright 23rd Annual Global Investment Conference
- Meridian Bioscience Reports Third Quarter Fiscal 2021 Results
- Meridian Closes Acquisition of BreathTek® Business
- Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
- Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021
- Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter
- Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay
- Meridian’s New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses
- Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
Chicago (773) 313-3741 | Naperville (630) 701-7755